ArticleCancer letters2025

Targeting MKK3/c-Myc interaction to overcome osimertinib acquired resistance in EGFR mutant lung cancer.

Zhen Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.